Cargando…

High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including Achromobacter xylosoxidans in Cystic Fibrosis

Cystic Fibrosis (CF) airways favor abnormal microbial development. Infections are considered as polymicrobial and competition can be observed between microorganisms. The current literature on bacterial competition in CF mostly consists of studies with limited numbers of strains, mainly focused on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Menetrey, Quentin, Dupont, Chloé, Chiron, Raphaël, Jumas-Bilak, Estelle, Marchandin, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513574/
https://www.ncbi.nlm.nih.gov/pubmed/33013789
http://dx.doi.org/10.3389/fmicb.2020.558160
_version_ 1783586411242323968
author Menetrey, Quentin
Dupont, Chloé
Chiron, Raphaël
Jumas-Bilak, Estelle
Marchandin, Hélène
author_facet Menetrey, Quentin
Dupont, Chloé
Chiron, Raphaël
Jumas-Bilak, Estelle
Marchandin, Hélène
author_sort Menetrey, Quentin
collection PubMed
description Cystic Fibrosis (CF) airways favor abnormal microbial development. Infections are considered as polymicrobial and competition can be observed between microorganisms. The current literature on bacterial competition in CF mostly consists of studies with limited numbers of strains, mainly focused on the major pathogens Pseudomonas aeruginosa (Pa) and Staphylococcus aureus (Sa) and does not give a comprehensive overview of the overall importance of bacterial interactions or the behavior of less often encountered emerging bacteria such as Achromobacter. In this context, we screened a panel of 39 strains from six CF patients, of either clinical or domestic environmental origin, distinguished according to genotype and belonging to four opportunistic pathogens, Pa (n = 15), Sa (n = 3), Stenotrophomonas maltophilia (Sm, n = 10) and Achromobacter xylosoxidans (Ax, n = 11). We investigated their capacity to compete in terms of growth, motility, and pigment production on agar media through 203 crossing experiments. Eleven strains selected via the initial screening results were further studied for competitive growth in liquid medium and biofilm formation. Competition was noted for 33% (67/203) of the pairs of strains with 85 modifications observed between monocultures and co-cultures, impacting growth (23.6%), motility (13.8%), and/or pigment production (6.1%). Under all conditions of the study (clinical, environmental strains; intra-, inter-patients; intra-, inter-species levels), competition was significantly more frequent among pairs of strains with at least one clinical strain. While Pa mainly outcompeted other species, in one patient with chronic colonization by Ax and sporadic colonization by Pa, we showed that some Ax inhibited the growth and pigmentation of Pa whereas biofilm formation was drastically reduced. Enlarging the panel of strains tested in competition assays gave new perspectives on the complex interactions taking place among the CF airway community. Indeed, the frequent occurrence of varied, strain-dependent interactions is revealed here. We report the first results of competition assays for Ax with the ability of certain strains to outcompete Pa. Our results are linked to the patient’s colonization history and question the importance of bacterial competitiveness in the colonization pattern of CF airways.
format Online
Article
Text
id pubmed-7513574
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75135742020-10-02 High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including Achromobacter xylosoxidans in Cystic Fibrosis Menetrey, Quentin Dupont, Chloé Chiron, Raphaël Jumas-Bilak, Estelle Marchandin, Hélène Front Microbiol Microbiology Cystic Fibrosis (CF) airways favor abnormal microbial development. Infections are considered as polymicrobial and competition can be observed between microorganisms. The current literature on bacterial competition in CF mostly consists of studies with limited numbers of strains, mainly focused on the major pathogens Pseudomonas aeruginosa (Pa) and Staphylococcus aureus (Sa) and does not give a comprehensive overview of the overall importance of bacterial interactions or the behavior of less often encountered emerging bacteria such as Achromobacter. In this context, we screened a panel of 39 strains from six CF patients, of either clinical or domestic environmental origin, distinguished according to genotype and belonging to four opportunistic pathogens, Pa (n = 15), Sa (n = 3), Stenotrophomonas maltophilia (Sm, n = 10) and Achromobacter xylosoxidans (Ax, n = 11). We investigated their capacity to compete in terms of growth, motility, and pigment production on agar media through 203 crossing experiments. Eleven strains selected via the initial screening results were further studied for competitive growth in liquid medium and biofilm formation. Competition was noted for 33% (67/203) of the pairs of strains with 85 modifications observed between monocultures and co-cultures, impacting growth (23.6%), motility (13.8%), and/or pigment production (6.1%). Under all conditions of the study (clinical, environmental strains; intra-, inter-patients; intra-, inter-species levels), competition was significantly more frequent among pairs of strains with at least one clinical strain. While Pa mainly outcompeted other species, in one patient with chronic colonization by Ax and sporadic colonization by Pa, we showed that some Ax inhibited the growth and pigmentation of Pa whereas biofilm formation was drastically reduced. Enlarging the panel of strains tested in competition assays gave new perspectives on the complex interactions taking place among the CF airway community. Indeed, the frequent occurrence of varied, strain-dependent interactions is revealed here. We report the first results of competition assays for Ax with the ability of certain strains to outcompete Pa. Our results are linked to the patient’s colonization history and question the importance of bacterial competitiveness in the colonization pattern of CF airways. Frontiers Media S.A. 2020-09-10 /pmc/articles/PMC7513574/ /pubmed/33013789 http://dx.doi.org/10.3389/fmicb.2020.558160 Text en Copyright © 2020 Menetrey, Dupont, Chiron, Jumas-Bilak and Marchandin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Menetrey, Quentin
Dupont, Chloé
Chiron, Raphaël
Jumas-Bilak, Estelle
Marchandin, Hélène
High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including Achromobacter xylosoxidans in Cystic Fibrosis
title High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including Achromobacter xylosoxidans in Cystic Fibrosis
title_full High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including Achromobacter xylosoxidans in Cystic Fibrosis
title_fullStr High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including Achromobacter xylosoxidans in Cystic Fibrosis
title_full_unstemmed High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including Achromobacter xylosoxidans in Cystic Fibrosis
title_short High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including Achromobacter xylosoxidans in Cystic Fibrosis
title_sort high occurrence of bacterial competition among clinically documented opportunistic pathogens including achromobacter xylosoxidans in cystic fibrosis
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513574/
https://www.ncbi.nlm.nih.gov/pubmed/33013789
http://dx.doi.org/10.3389/fmicb.2020.558160
work_keys_str_mv AT menetreyquentin highoccurrenceofbacterialcompetitionamongclinicallydocumentedopportunisticpathogensincludingachromobacterxylosoxidansincysticfibrosis
AT dupontchloe highoccurrenceofbacterialcompetitionamongclinicallydocumentedopportunisticpathogensincludingachromobacterxylosoxidansincysticfibrosis
AT chironraphael highoccurrenceofbacterialcompetitionamongclinicallydocumentedopportunisticpathogensincludingachromobacterxylosoxidansincysticfibrosis
AT jumasbilakestelle highoccurrenceofbacterialcompetitionamongclinicallydocumentedopportunisticpathogensincludingachromobacterxylosoxidansincysticfibrosis
AT marchandinhelene highoccurrenceofbacterialcompetitionamongclinicallydocumentedopportunisticpathogensincludingachromobacterxylosoxidansincysticfibrosis